identified UCN-01, a staurosporine derivative, as a potential agent capable of reactivating FOXO3, reversing fibroblast phenotypic changes, and ameliorating pulmonary fibrosis (40). The gene discussed is FOXO3; the disease is pulmonary fibrosis.